DIAGNOSTIC SIGNIFICANCE OF ENDOCAN AND ENDOGLIN AS MARKERS OF ENDOTHELIAL DYSFUNCTION IN THE PATHOLOGY OF THE CARDIOVASCULAR SYSTEM
Journal: The Bulletin of Contemporary Clinical Medicine
Year: 2023

Introduction. Endothelial dysfunction is a key link in the atherosclerotic process and therefore the study of specific markers may provide new opportunities for the development of therapeutic strategies for its correction. Aim of this work was to study the role of new biomarkers of endothelial dysfunction (endocan and endoglin) in early detection and prognosis of cardiovascular pathology. Material and methods. Meta-analysis of the literature sources in the scientific electronic bibliographic dat